🟢 Surgepays is trading 6.44% up in pre-market with no confirmed catalyst

Surgepays is trading at $0.13, up 6.44% in pre-market; no confirmed driver has been identified.

• No new company-specific announcement explaining the pre-market move was found; the latest identified company news was the October 15 GrowthLine partner-brand launch, which is earlier context, not a confirmed catalyst.
• Broader markets were sharply lower before the open, making a market-wide tailwind an unlikely explanation; available evidence does not establish what is driving the gain.